Congratulations DrTrishaPeel and the ASAP Trial team!!

This is a make deal - the Australian peak body and award for clinical trials. ACTA: Australian Clinical Trials Alliance

Well deserved. Doing clinical trials that make a difference!

nejm.org/doi/full/10.10…

Do you have 'carriage' isolates of Strep anginosus/Step milleri? Ideal samples would be i.e isolates from studies done for carriage of pneumococcus or Group A Strep. If so get in touch..... Steven Tong Josh Osowicki Claire Turner

Great opportunity to join Mark_Davies_Lab with whom I work very closely.

Be involved in cutting edge bacterial genomics studies such as these recently published.

nature.com/articles/s4146…

nature.com/articles/s4146…

thelancet.com/journals/lanmi…

Our newest paper, exploring the association between ID consult and mortality in GN-BSI, published in Clinical Infectious Diseases! Main takeaway – ID consult saves lives and reduces antibiotic use! A 🧵: 1/

Steven Tong Brad Langford Kevin Schwartz IDSA
#IDTwitter

doi.org/10.1093/cid/ci…

🆕️🔥Retrospective population wide cohort study Clinical Infectious Diseases Sean Ong Steven Tong
Early ID consultation was associated with reduced mortality in patients with Gram-negative bloodstream infection # #IDXposts academic.oup.com/cid/article/do…

Abstracts for the ASIDANZ CRN Meeting 27-28 July #goldcoast close 19 May 2024. Stellar line up of speakers including Preeti Malani Steven Tong David Paterson Jason Trubiano 🆔
See: bit.ly/48YRQOS
*If you register for BOTH BJI & CRN 2024 you’ll get 20% off your CRN reg.*

This article has all we need to know about funding COVID antivirals. We can’t accept $1.3 billion when we haven’t built on the evidence on when and in whom they should be used. We shouldn’t be paying $1100 for a 5 day course of antivirals #auspol dailymail.co.uk/news/coronavir…

Some follow-up to the below. Call from Dr. Nick Coatsworth for doing a trial to determine if we should keep spending such amounts on molnupiravir

dailymail.co.uk/news/coronavir…

Fascinating study. Provocative findings.
Are we using too much pip-tazo?
And I still don’t get why we use so much anti-pseudomonal agents for empiric sepsis

2/2 Australia's top #phagetherapy experts have secured a $4.34M grant from @NHMRC. They will collaborate with the largest-ever trial team for S. aureus bacteraemia, #SNAP , to conduct a phase II trial investigating adjunctive phage therapy. #SABREPhiTrial
@iredell_lab
Steven Tong

Combination of anti-staphylococcal β lactam with standard therapy compared to standard therapy alone for the treatment of MRSA bacteraemia: a post hoc analysis of the CAMERA2 trial using a desirability of outcome ranking (DOOR) approach

✅ Just Accepted
bit.ly/3QkiZFy

Success!
Tasked with finding French translations of Louise Penny books.
She lives in and writes about Quebec. Beautiful murder mysteries about Inspector Gamache.
Written in English. My wife wants to read them in French!

Another big win for Iredell Lab, #phageteam ! 🙌
Staphylococcus aureus bacteraemia treated w/ #phagetherapy to improve outcomes - our #SABRE -Phi clinical trial got funded ($4.3M), tnx to NHMRC!
nhmrc.gov.au/sites/default/…
Led by Ameneh Khatami & Jon Iredell
University of Sydney NSW Health

🎉Our new study published today in The Lancet Microbe: SpyCATS longitudinal household cohort study of #StrepA carriage and infection and transmission in The Gambia! thelancet.com/journals/lanmi… [1/7]

New research article

#Streptococcus pyogenes carriage and infection within households in The Gambia: a longitudinal cohort study

thelancet.com/journals/lanmi…

#StrepA #OpenAccess #OA

Just some of the great speakers Joshua Davis Asha Bowen Jason Trubiano 🆔 we have for ASIDANZ CRN2024.
Abstracts close 19 May 2024 so if you are an Early or Mid Career #ID #micro clinician researcher in AU Register/ Submit your abstract now👇
See: bit.ly/48YRQOS.

Steve Tong Steven Tong gracing us at Duke Infectious Diseases & Duke Clinical Research Institute on his North American tour to spread the gospel of Staph aureus treatment & the SNAP Trial juggernaut

Sensational overview by Steven Tong on the need for more randomized trials for Staph aureus bacteremia -- limited studies to date, despite how common and serious this problem is. Underscores the importance of the multinational SNAP Trial.

In Open Forum Infectious Diseases, Neta Petersiel and colleagues analyze the CAMERA2 trial data within the DOOR framework, to determine whether there were differences between the standard therapy and the combination therapy groups with this broader consideration.

Read: bit.ly/3JJufHN

The drug that Australia spent most money on in 2022-2023?

.
.
.
.
.
.

Molunupiravir
AUD $650 million

pbs.gov.au/statistics/exp…